Adma Biologics ADMA
NASDAQ ADMA
$9.96 -0.16 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Total Current Liabilities (2011 - 2026)

Updated

Adma Biologics (ADMA) posted Total Current Liabilities of $75.76 million for Q2 2026, up 1.1% from $74.94 million a year earlier and up 3.0% from the prior quarter.

Analysis

Adma Biologics (ADMA) Total Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025, Adma Biologics' Total Current Liabilities came in at $69.54 million, up 25.2% from FY2024.

  • Annual Total Current Liabilities has increased for eight consecutive years, with a five-year compound annual growth rate of 28.4% (FY2020 to FY2025).
  • In prior years, Adma Biologics' Total Current Liabilities was $55.54 million in FY2024 (+11.5%), $49.81 million in FY2023 (+26.8%), $39.27 million in FY2022 (+29.3%) and $30.38 million in FY2021 (+52.3%).
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities in data going back to Q2 2011.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last 11 quarters, with growth averaging 22.3% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q3 2021, with growth of 96.3%; the weakest was Q3 2023, with a decline of 5.8%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $73.54 million (Q1 2026), $69.54 million (Q4 2025) and $56.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Adma Biologics 2.28 Bn 1.86 Bn 86.28 Mn 75.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.76 Mn
Mar 31, 2026 73.54 Mn
Dec 31, 2025 69.54 Mn
Sep 30, 2025 56.49 Mn
Jun 30, 2025 74.94 Mn
Mar 31, 2025 53.50 Mn
Dec 31, 2024 55.54 Mn
Sep 30, 2024 44.90 Mn
Jun 30, 2024 44.20 Mn
Mar 31, 2024 53.10 Mn
Dec 31, 2023 49.81 Mn
Sep 30, 2023 41.84 Mn
Jun 30, 2023 41.95 Mn
Mar 31, 2023 36.73 Mn
Dec 31, 2022 39.27 Mn
Sep 30, 2022 44.44 Mn
Jun 30, 2022 28.07 Mn
Mar 31, 2022 31.57 Mn
Dec 31, 2021 30.38 Mn
Sep 30, 2021 32.34 Mn
API Access

Adma Biologics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ADMA&period=max&api_key=YOUR_API_KEY